Section Arrow
Quote
JUNS.NASDAQ
- Jupiter Neurosciences Inc
Quotes are at least 15-min delayed:2026/02/15 20:58 EST
Regular Hours
Last
 0.5779
-0.0011 (-0.19%)
Day High 
0.5779 
Prev. Close
0.579 
1-M High
1.04 
Volume 
23.77K 
Bid
0.5503
Ask
0.61
Day Low
0.550001 
Open
0.552 
1-M Low
0.48 
Market Cap 
19.93M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.59 
20-SMA 0.71 
50-SMA 0.94 
52-W High 3.33 
52-W Low 0.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.23/-0.26
Enterprise Value
19.95M
Balance Sheet
Book Value Per Share
0.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
638.04K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.2-0.0255-11.31%-- 
IMUXImmunic0.9125+0.0424+4.87%-- 
MLECMoolec Science SA8.63+3.53+69.22%-- 
BRTXBioRestorative Therapies0.285+0.0395+16.09%-- 
IBRXImmunityBio5.945-0.675-10.20%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.